Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
26
NLH.V Quote, Financials, Valuation and Earnings
Last price:
$0.28
Seasonality move
:
-4.27%
Day range:
$0.28 - $0.28
52-week range:
$0.22 - $0.35
Dividend yield:
0%
P/E ratio:
23.53x
P/S ratio:
0.59x
P/B ratio:
0.94x
Volume:
221.6K
Avg. volume:
19.6K
1-year change:
--
Market cap:
$24.4M
Revenue:
$35.3M
EPS (TTM):
$0.01
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Nova Leap Health Corp. has 114.08% upside to fair value with a price target of -- per share.
NLH.V vs. S&P 500
-
Over the past 5 trading days, Nova Leap Health Corp. has underperformed the S&P 500 by -4.72% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Nova Leap Health Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nova Leap Health Corp. has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Nova Leap Health Corp. reported revenues of $11.4M.
Earnings Growth
-
Nova Leap Health Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Nova Leap Health Corp. reported earnings per share of $0.01.
Enterprise value:
26.5M
EV / Invested capital:
0.87x
Price / LTM sales:
0.59x
EV / EBIT:
17.89x
EV / Revenue:
0.63x
PEG ratio (5yr expected):
6.51x
EV / Free cash flow:
12.95x
Price / Operating cash flow:
11.99x
Enterprise value / EBITDA:
10.26x
Gross Profit (TTM):
$15.4M
Return On Assets:
3.28%
Net Income Margin (TTM):
2.49%
Return On Equity:
4.05%
Return On Invested Capital:
3.54%
Operating Margin:
5.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $35.6M | $35M | $41.9M | $8.7M | $11.4M | |
| Gross Profit | $11.6M | $12.6M | $15.4M | $3.1M | $4.2M | |
| Operating Income | -$247.4K | $1.3M | $1.5M | $283.9K | $576.5K | |
| EBITDA | $1.1M | $2.2M | $2.6M | $483.2K | $898K | |
| Diluted EPS | -$0.02 | -$0.01 | $0.01 | -$0.00 | $0.01 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $15M | $7.1M | $4.1M | $4.5M | $5.3M | |
| Total Assets | $32M | $34.9M | $29.8M | $28.4M | $32.8M | |
| Current Liabilities | $6.2M | $5.9M | $3.1M | $2.6M | $5.7M | |
| Total Liabilities | $8M | $8.3M | $4.6M | $3.6M | $6.7M | |
| Total Equity | $24M | $26.6M | $25.3M | $24.8M | $26.1M | |
| Total Debt | $4.3M | $3.7M | $2.3M | $1.6M | $1.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.8M | $2.2M | $2.1M | $390.3K | $592.1K | |
| Cash From Investing | -$43.4K | -$339.7K | -$3.6M | -- | $13.5K | |
| Cash From Financing | -$3.2M | -$1.5M | $1.8M | -$124.7K | -$345.4K | |
| Free Cash Flow | $1.8M | $2.2M | $2M | $390.3K | $592.1K | |
NLH.V
Sector
Market Cap
$24.4M
$27.9M
Price % of 52-Week High
80%
50.56%
Dividend Yield
0%
0%
Shareholder Yield
-2.18%
-1.55%
1-Year Price Total Return
--
-17.49%
Beta (5-Year)
1.632
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.30
200-day SMA
Sell
Level
$0.28
Bollinger Bands (100)
Sell
Level
0.27 - 0.33
Chaikin Money Flow
Sell
Level
-175.1K
20-day SMA
Sell
Level
$0.31
Relative Strength Index (RSI14)
Sell
Level
39.91
ADX Line
Sell
Level
17.12
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$0.30
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Buy
Level
8
On Balance Volume
Neutral
Level
482.6K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.5488)
Buy
CA Score
(Annual)
Level (1.7423)
Buy
Beneish M-Score
(Annual)
Level (-3.1011)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.8516)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nova Leap Health Corp. acquires, manages, and builds home care services companies that provide support to clients and their families at home. It operates through the US and Canada geographical segments. Its services include bathing, dressing, grooming, meal preparation, housekeeping, errands, transportation, and medication reminders. The company was founded on November 16, 2015 and is headquartered in Halifax, Canada.
Stock Forecast FAQ
In the current month, NLH.V has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NLH.V average analyst price target in the past 3 months is --.
-
Where Will Nova Leap Health Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nova Leap Health Corp. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Nova Leap Health Corp.?
Analysts are divided on their view about Nova Leap Health Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nova Leap Health Corp. is a Sell and believe this share price will drop from its current level to --.
-
What Is Nova Leap Health Corp.'s Price Target?
The price target for Nova Leap Health Corp. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NLH.V A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nova Leap Health Corp. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NLH.V?
You can purchase shares of Nova Leap Health Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nova Leap Health Corp. shares.
-
What Is The Nova Leap Health Corp. Share Price Today?
Nova Leap Health Corp. was last trading at $0.28 per share. This represents the most recent stock quote for Nova Leap Health Corp.. Yesterday, Nova Leap Health Corp. closed at $0.28 per share.
-
How To Buy Nova Leap Health Corp. Stock Online?
In order to purchase Nova Leap Health Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get NLH.V Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NLH.V
Sector
P/E ratio
23.53x
23.75x
PEG ratio
6.51x
-0.01x
P/B ratio
0.94x
1.81x
Price / LTM sales
0.59x
1.59x
Growth Metrics
NLH.V
Sector
Revenue growth
30.26%
4.6%
Earnings growth
303.03%
10.88%
Revenue (5-year growth)
8.85%
6.45%
Earnings forecast
--
-$0.21
Profitability
NLH.V
Sector
Profitability FY 2024
$12.7M
$3.6M
Return on invested capital
3.54%
-31.84%
Return on assets
3.28%
-27.96%
Return on equity
4.05%
-37.63%
Earnings Date
Last Earnings Date
Dec
31
Next Earnings Date
Dec
31
Estimated Next Earnings Date
Apr
1
Balance Sheet
NLH.V
Sector
Total cash
$2.2M
$26.3M
Short term investments
--
$25.7M
Total assets
$32.2M
$76.9M
Long term debt
$1.6M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 40.26% over the past day.
Buy
71
ZCSH alert for Dec 30
Grayscale Zcash Trust (ZEC) [ZCSH] is down 4.56% over the past day.
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 3.19% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
